is now part of

Cardiva Medical is excited to be part of Haemonetics to expand our reach!

Learn More

6-12F (15F max outer diameter) Venous Closure

The only FDA-approved closure device for use following
cardiac ablations*

FDA Approved FDA Approved


Proven by EPs in the ambulate pivotal trial


VASCADE MVP was evaluated in the AMBULATE pivotal trial. AMBULATE was a multicenter, randomized clinical trial with 204 patients randomized 1:1 to VASCADE MVP or manual compression.

Read the full JACC EP published articleJust Published

Opioid Use1

Number of Patients Receiving Opioids Post-Procedure

Manual Comp = 37 pts
VASCADE MVP = 15 pts

Patient Satisfaction with Duration of Bedrest

Comparison to Bedrest from a Previous Cardiac Ablation Procedure

Manual Comp = 5.6 vs.
VASCADE MVP = 7.9 mean

All Patients

Manual Comp = 5.1 vs.
VASCADE MVP = 8.3 mean

1 As demonstrated in the AMBULATE Pivotal Trial. | * Cardiac ablations requiring two or more access sites within the same limb. See VASCADE MVP IFU 3972 Indications for Use

VASCADE MVP® Videos and Literature

VASCADE MVP® Procedure
VASCADE MVP® Procedure - Multi Vessel Closure Following AF Ablation Dr Rodney Horton
VASCADE MVP® Procedure - Multi Vessel Closure Following Cardiac Cryoablation Dr Suneet Mittal
VASCADE MVP® Procedure - WATCHMAN Access Site Closure Dr Suneet Mittal
Benefits of VASCADE MVP®: Patient, Physician and Nurse Perspectives

Call us today
Toll Free: (in the U.S.)

Need to speak
with a Cardiva

Request a Call

1615 Wyatt Drive
Santa Clara, CA 95054